Queen's Birthday Honour for Professor Georgina Long

8 June 2020
Congratulations to Melanoma Institute Australia Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List announced today by the Governor-General.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
‘This is well deserved recognition of Professor Long’s lifesaving work and ground-breaking research,’ said fellow MIA Co-Medical Director, Professor Richard Scolyer. ‘She has changed the face of melanoma treatment around the world and many thousands of people are alive today thanks to her intellect, determination and passion.
‘It is due to her research and thought leadership globally that the world is now realistically looking towards a day with zero deaths from melanoma,’ he added.
Professor Long is one of the world’s most renowned melanoma clinicians and researchers with her clinical trials tripling life expectancy for some advanced melanoma patients and essentially curing others.
She leads the clinical trials team at MIA, with a focus on targeted therapy and immune-oncology in melanoma, and is Principal Investigator on Phase I, II and III trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases.
Professor Long is a fierce advocate that recent advances and breakthroughs in melanoma treatment stem from the collective effort of the dedicated multi-disciplinary team at MIA that she co-leads with her colleague and friend Professor Scolyer.
In a double world first, she is the first woman and the first Australian to be President of the prestigious US-based Society for Melanoma Research (SMR). She has authored over 300 publications in melanoma clinical and translational research, including in the world’s leading scientific high-impact journals such as the New England Journal of Medicine and The Lancet, and has presented at hundreds of international conferences.
Professor Long’s Queen’s Birthday Honour follows numerous awards including being named the 2018 Outstanding Researcher of the Year at the NSW Premiers Awards for Outstanding Cancer Research and receiving the prestigious Research Australia, GSK Research Excellence Award in 2018 and the Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research in 2016.
‘Professor Long’s recognition in the Queen’s Birthday Honours List is a proud day for all of us here at Melanoma Institute Australia,’ said CEO Matthew Browne.
‘Not only is she saving lives and changing the future for melanoma patients around the world, but she is also an inspiring role model for all young Australians, particularly women, who may be working towards a career in science and medicine,’ he said.

Australasian Melanoma Conference AMC2021
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.

Sharing our knowledge of melanoma on the global stage
As leaders in the field of melanoma, clinicians and researchers from MIA will be sharing their knowledge at the virtual 10th World Congress of Melanoma.

Melanoma patients and their families urged to speak up and put national spotlight on melanoma.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.

An inspiring WA Melanoma Community Forum
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.

Family of 8-year-old with melanoma calls on all Australians to step up to help save lives
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.

Rethinking skin surveillance for high-risk melanoma patients
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.

Australia's oldest melanoma survivor steps up to save lives on his 105th birthday
Melanoma research saved Bert's life at 101 and now he wants to give back.

Predicting disease spread in thin melanoma
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.

Exploring our own clinical questions through MIA's new trials initiative
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.

Young researchers awarded Fellowships to pursue innovative treatments for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.

Young researchers receive boost to develop innovative treatment for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.

Launch of Melanoma March 2021
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.

Olivia Vivian announced as MIA ambassador
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.

Melanoma breakthrough - neoadjuvant treatment saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.

Melanoma breakthrough - neoadjuvant therapy saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.

Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.

Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.

A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.

Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.

It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.